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1573 ABSTRACT 
A medication infusion system provides redundant safety 
and includes condition detecting and informational 
alarm signal generating apparatus for indicating if (1) a 
fluid leak occurs in different portions of the system; (2) 
a programmable input from a patient or physician 
would result in exceeding a safe dosage limit; (3) the 
reservoir containing medication has been filled; (4) the 
intended medication pumping does not correlate with 
the pumping actually effected; ( 5 )  battery voltage is 
low; (6) the medication reserve is low; and (7) the sys- 
tem has been switched off. The apparatus may provide 
subcutaneous electrical, thermal, or audible stimulation 
to the patient and also provides a signal which a physi- 
cian may monitor. The stimulation may be coded to 
separately identify each above-listed deviation in nomi- 
nal system performance. In addition, the number of 
medica- 
scheF is provided which matches the patient 
3,672,352 6/1972 Summers ............................. 128/630 medication requests are correlated with 
3,946,73 l 3/1976 Lichtenstein ......................... 604/66 tion dispensing to proper An identi& 
4,037,598 7/1977 Georgi ........................ 128DIG.  13 
4,140,131 2/1979 Dutcher ........................ 128/419 PT 
4,191,181 3/1980 Franetzki et al. ...... 128DIG.  12 X 
4,308,866 VI982 Jelliffe et al. ......................... 604/31 
4,373,527 2/1983 Fischell .................. 128DIG.  13 X 9 Claims, 9 Drawing Figures 
with his Or her corresponding medication* 
https://ntrs.nasa.gov/search.jsp?R=20080008232 2019-08-30T03:35:38+00:00Z
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4,6 19,653 
1 2 
expels drug through valves, in particular one-way 
valves. The Ellinwood device is not programmable; it 
varies dosage by opening and closing portals or select- 
ing a dose of medication from one of a plurality of 
5 pumps having different dosage volumes and/or differ- 
ent medications stored therein. Svstem oDeration relat- 
APPARATUS FOR DETECTING AT LEAST ONE 
PREDETERMINED CONDITION AND 
PROVIDING AN INFORMATIONAL SIGNAL IN 
RESPONSE THERETO IN A MEDICATION 
INFUSION SYSTEM 
ing to pressure integrity checks during filling, leakage 
problems, patient and doctor interaction with the dis- STATEMENT OF GOVERNMENTAL INTEREST 
The invention described herein was made in the per- penser, and dosage input programming, and informa- 
formance of work under NASA Contract No. NDPR lo tional outputs which correspond to such system opera- 
S-63983B and is subject to the provisions of Section 305 tion conditions are not considered. 
of the National Aeronautics and Space Act of 1958 (72 An invention of Blackshear (U.S. Pat. No. 3,731,681) 
Stat. 435; 42 U.S.C. 2457). shows another infusion pump without such features. 
While disclosing an implanted bellows pump arrange- 
‘ s  ment fed through a self-sealing plug, the Blackshear REFERENCE TO RELATED CASES 
This is a continuation-in-part of a patent application pump does not look for pressure integrity before filling 
filed on Apr. 27, 1979 Ser. No. 34,155, now U.S. Pat. the device with drug. Further, because there is no input 
NO. 4,373,527. The inventor in the related case was R. check valve and because the pressure in the device is 
E. Fischell. above that of the body in which it is implanted, leakage 
in Blackshear can be dangerous. This is particularly true 
because the full reservoir will typically contain a lethal 
FIELD OF THE INVENTION 
The present invention relates to apparatus for detect- dose of medication if delivered Over a short period of 
ing selected conditions, including deviations in nominal time. It is thus particuiarly significant that no for 
performance, in a system for dispensing medication to a indicating to a patient either proper or non-opthal 
living being. Although mainly intended for use with 25 performance is provided. 
motherapeutic agents, the invention extends to use in 
infusion of any liquid (such as blood) or colloidal sus- 30 safety backed up by an 
pension, or gas or granulated solid, which may be dis- 
pensed by the system and may provide a curative or 
healing effect. Although a principal use of the invention 
is in implantable devices, the principles of the invention 
infusion of medication. 
human patients requiring infusions Of a drug, such as 
morphine, heparin, Or any of various Other the- 
Richter (U.S. Pat. No. 3,894,538) considers, in a med- 
icine supplying device, one safety feature: an exit plug 
for from entering the device 
signal providing 
feature is absent, 
A device by Jacob (U.S. Pat. No. 4,033,479) provides 
a bellows pump which maintains drug in a chamber at a 
drug from the chamber into a body. The bellows varies 
the chamber volume to maintain constant pressure. It is 
not of importance to Jacob how much pressure there is 
in the chamber-it is above body pressure-but, rather, 
Various techniques and devices have been suggested 40 the concern is to keep pressure constant. Leakage Out 
from the valve and the spurting Of drug into the 
be problems inherent in the Jacob device. Apparatus 
any living body (such as domestic and to the and for limiting drug outflow. However, redundant 
also apply to systems external to a living being for the 35 “constant internal pressure‘” A valve Owns to 
TECHNOLOGICAL CONTEXT OF THE 
INVENTION 
and are currently under study which address the prob- 
a living body. Of these techniques and devices, how- 
ever, the provision of redundant safety features and the 
indication of certain vital operation conditions are 45 conditions is not Present. 
rarely addressed and then to only a limited extent. Portner in U.S. Pat. No. 4,126,132 and its predecessor 
One liquid infusion device discussed in U.S. Pat. No. case, ser. No. 599330 filed July 28, 1976, discuss the use 
4,077,405 by Haerten et a1 discloses a controllable dos- Of alarms in an intravenous delivery system. Sensors for 
ing arrangement which provides for human operator detecting air in the delivery lines by making Pressure 
interaction. A syringe forces liquid through a pressure 50 memmments and for detecting the amount of 
valve into a supply reservoir and a bellows pump forces fluid in a Supply bottle Provide input to an audible Or, 
drug from the reservoir through a flow limiter into the visual alarm. The use of alarms for a broad Variety of 
body. The Haerton et a1 patent teaches an “overpres- conditions-which alarms would increase the safety Of 
sure” technique where liquid in the reservoir is at a the system-is not discussed. Furthermore, the applica- 
pressure above that at the discharge point. This device 55 tion Of alarms to implantable medication release systems 
fails to address various safety problems such as leakage, is not considered. 
excessive pumping, and excessive requests for drug. In Franetzki et a1 US. Pat. No. 4,191,181 suggests the 
particular, should the input control valve in this pa- use of negative pressure, external to the medication 
tented device leak, a flood of liquid would enter the reservoir, as a safety feature in a medication dispensing 
body because of the pressure differential and the lack of 60 unit. However, this reference has no teaching of means 
any back-up safety mechanism. No provision for detect- for detecting and alerting the patient and/or physician 
ing leaks in the device, for signalling selected deviation regarding the structural and operational state of the 
in nominal performance, for restricting the number of unit, so as to provide information regarding e.g. leaks 
or quantity of drug doses, or for monitoring proper detected within the unit, excessive medication requests, 
operation of the device is suggested. 65 stored medication level, blockage of the medication 
Like Haerten et al, Ellinwood in U.S. Pat. No. dispenser’s output, etc. 
3,692,027 teaches an implanted, self-powered drug dis- Several recent publications have also underscored the 
penser having a bellows pump which is fed through and advantages of a medication infusion device which is 
lem of dispensing a drug or other medicative liquid into W’Ider relatively high constant Pressure would appear to 
a Patient Of such conditions Or Other 
3 
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implantable. Two articles by Rhode et a1 (“One Year of generated, indicating that the relative negative pressure 
Heparin Anti-coagulation;” Minnesota Medicine; Octo- in the medication reservoir had increased. On the one 
ber, 1977 and “Protracted Parenteral Drug Infusion in hand, the likelihood of a leak out is diminished and, on 
Ambulatory Subjects Using an Implantable Infusion the other, the patient is informed if a leak out path ex- 
Pump”; American Society for Artificial Internal Organs 5 ists. Further, any other leak to or from the medication 
Transactions, Volume XXIII; 1977) describe an implant- reservoir would be sensed by a moisture detector out- 
able infusion pump which comprises a hollow disk sepa- side the reservoir and an indicative informational signal 
rated into two chambers by a bellows. A volatile fluoro- generated. 
carbon in the outer chamber forces drug from the inner Also at the outlet where medication from the medica- 
chamber through a filter and catheter into a patient. 10 tion reservoir is dispersed is an element for counting 
Filling of the inner chamber is accomplished by pene- dispensed dosages of medication, which count can be 
trating a self-sealing septum which apparently forms a compared to medication requests, thus providing an 
wall of the inner chamber. The condensation of the operational indicator and safety feature. If, for example, 
fluorocarbon provides energy for cyclical pumping. No the pulsatile pump fails to function or its output is 
antechamber, no check for pressure integrity before 15 blocked (e.g. at the catheter), there will be a significant 
filling or during operation, no programming means, and count discrepancy, and an informational signal will be 
no patient or doctor interaction with the device are provided. This feature would be of great significance in 
contemplated. Detecting the status of such elements and any medication infusion system whether the dispensing 
providing corresponding informational signals are thus pump is implanted or external to the body. 
not considered. 20 In programming the medication infusion system, con- 
Finally, an article by Spencer (“For Diabetics: an venience and safety are major concerns. Thus, in addi- 
electronic pancreas;” IEEE-Spectrum; June, 1978) dis- tion to a programmable rate of medication input, a hard- 
cusses current trends in the drug pump field. Prepro- wired limit is also included to limit the dispensing of 
gramming the rate of drug flow over time depending on medication. If requests exceed the limits set by the pro- 
food intake is mentioned. Efforts in the development of 25 gram, the hardwired limits will inhibit the pulsing of 
a bellows pump are also discussed. Spencer further excessive medication into the patient and an informa- 
mentions the use of alarm sounds if a pump fails to tional signal to the patient will be provided. 
provide drug in accordance with the preprogrammed Safe filling is also a concern in the present invention. 
rate. The Spencer article generally discusses drug dis- To assure that the patient receives the proper medica- 
penser technology but fails to address many specific 30 tion, a matching procedure of patient to medication is 
problems. As in other cited systems redundant safety employed. If an identification code on the medication 
features such as providing an antechamber; leak detec- does not match a patient identification code, it will not 
tion; providing distinctive subcutaneous stimulation or be injected into the medication reservoir from which 
audio alarm to indicate various selected conditions and dispensing takes place. Like the bar coding of consumer 
deviations in nominal performance; providing a safe 35 products, a similar medication coding correlated to a 
method of programming the device regardless of work, patient and his needs is provided. An attempt at refilling 
food-intake, or time schedules; and maintaining the a patient’s unit with improper medication will prompt a 
reservoir pressure below ambient body pressure so that warning signal to the physician. Filling the reservoir is 
a leak would result in body fluids entering the device as also performed in a safe manner, with an indicator sig- 
opposed to a fatal dose of drug entering the body (at a 40 nal being activated when the reservoir is filled. 
high, constant pressure) are not considered. The informational signal to be provided when an 
improper operational condition is sensed can take vari- 
ous forms. A subcutaneous electrical, thermal, or acous- 
tic signal in the form of a single pulse or multiple pulses 
the present invention provides extensive redundancy to 45 which can have various pulse widths or pulse intervals 
SUMMARY OF THE INVENTION 
In a field where safety and reliability are paramount, 
prevent and, if appropriate, inform a patient of less than 
optimal system performance. 
According to the medication infusion system de- 
scribed in the above-identified, related patent applica- 
tion, an antechamber is provided, which is filled with 50 
saline solution or a bacteriacidal solution or a non-lethal 
volume of the medication, to act as a buffer between the 
medication intake point and a medication reservoir in 
the device. The medication reservoir may contain a 
lethal dose of drug or other medication if released all at 55 
once. The input to the medication reservoir is thus iso- 
lated from the body by a filter, a one-way inlet valve, 
the antechamber and a septum which serves as a self- 
sealing opening to the antechamber. All of these ele- 
ments are provided to prevent the leakage of medica- 60 
tion from the medication reservoir into the body. As a 
further measure however, the medication reservoir is 
maintained at a pressure below the ambient body pres- 
sure. Thus, even if the inlet valve and septum leak, body 
fluids would enter the antechamber and ooze very 65 
slowly into the medication reservoir through the flow- 
impeding filter. A pressure build-up in the medication 
reservoir would be detected and an informational signal 
can inform the patient of an existing or potentially unde- 
sued operating condition or proper operation if that is 
desired. In addition, provision is made for a physician to 
interrogate the medication infusion system to determine 
exactly what the condition is that is causing the alarm. 
For some patients the physician may wish to have the 
same informational signal provided for each different 
alarm with a unique signal (depending on the cause of 
the alarm) being made known by telemetry but only 
discernible by the physician. 
The physician could also be provided with a means to 
disable any of the informational signals for a variety of 
reasons. For example, if the moisture detector became 
defective so that it incorrectly caused an informational 
(alarm) signal to be generated, then the physician may 
elect to turn that alarm off rather than surgically remov- 
ing the device implanted in the patient. A telemetry 
means can be provided to determine which informa- 
tional signals are enabled and which, if any, are dis- 
abled. 
Various informational signals to indicate low battery 
voltage, medication reservoir nearly empty of medica- 
tion, and medication infusion pump switched off are 
4,6 19,653 
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provided which could enhance the safe operation of an 
implanted or external pump in a medication infusion 
system. Additionally, indications are given when refill 
of the medication reservoir has been completed and if 
2) included within the medication dispensing unit 10. 
Fill commands to the medication injection unit 18 ema- 
nate from a medication programming unit 24. A pa- 
tient’s programming unit 14 (which may also communi- 
moisture is detected either between the reservoir and 
the outer casing or inside the compartment housing the 
electronics portion of the medication infusion system. 
DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an illustration showing a general block 
diagram of a medication infusion system employing the 
present invention. 
FIGS. 2 and 3 are illustrations showing a front cut- 
away and a top perspective view, respectively, of a 
medication dispensing unit in a medication infusion 
system. 
FIG. 4 shows, in detail, a top view of a combination 
moisture detectorhwitching unit which senses when 
various predetermined operating conditions exist. 
FIG. 5 is a cross-section side view of the combination 
moisture detectorhwitch unit shown in FIG. 4. 
FIG. 6 shows one embodiment of an informational 
signal generator. 
FIG. 7 is a cross-section view of one embodiment of 
a pump which may be included in the present system. 
FIG. 8 is a block diagram showing electronic compo- 
nents of the system. 
FIG. 9 shows signals representing various pulse- 
coded alarm patterns used in informing a patient of 
various deviations from normal operating conditions. 
DESCRIPTION OF THE INVENTION 
Referring to FIG. 1, the various portions of a pro- 
grammable medication infusion system are shown. A 
medication dispensing unit 10 implantable in or external 
to a patient’s body can be programmed either by the 
medication programming system 12 or by the patient’s 
programming unit 14. Commands from the medication 
programming system 12 emitted from the communica- 
tion head 16 are transmitted to electronics in the medi- 
cation dispensing unit 10 in order to program and effec- 
tuate the infusion of medication into the body in a safe, 
controlled fashion. Furthermore, the communication 
head, 16, is used to receive signals telemetered out of 
the implanted unit 10. Thus, the communication head, 
16 is really a command transmitting antenna and a tel- 
emetry receiving antenna. This antenna might typically 
be a few hundred turns of fine copper wire having ap- 
proximately the same diameter as a similarly configured 
antenna in the implanted medication dispensing unit 10. 
The communication head 16, might also provide a 
source of an alternating magnetic field coupled to the 
similar coil in the implanted unit 10, to provide energy 
for recharging a rechargeable cell contained in 10. Fur- 
thermore the inductively coupled energy could be used 
to power the command and telemetry systems of the 
implanted unit 10. 
The medication programming system 12 is also capa- 
ble of reading information telemetered out from the 
medication dispensing unit 10, which information re- 
lates to the amount of medication dispensed over a 
specified time period as well as other data of value to 
the physician. Further, the medication programming 
system 12 is capable of calibrating the medication per 
pulse which is dispersed by the medication dispensing 
unit 10. A medication injection unit 18 is connected to a 
double hypodermic syringe 20 which is used to provide 
medication to a medication reservoir 22 (shown in FIG. 
5 cate, by inductivetransmission for example, with the 
medication dispensing unit 10) is controlled by the user 
(typically the patient) to request doses of medication, 
i.e. to obtain self-medication. The dispensing of dosage 
requests is limited by various elements included in the 
IO programmable memory units (shown in FIG. 8 as 106 
15 
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25 
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and 108) and in the hardwired limit controls (shown at 
110 and 112 in FIG. 8) all of which are found in the 
medication dispensing unit 10. 
To recharge a power cell 26 (see FIG. 8) contained 
within the medication dispensing unit 10 (when the 
power cell 26 is a rechargable type), an external charg- 
ing head 28 connected to a battery charging unit 30 is 
included. The need for the charging head 28 and battery 
charging unit 30 can be obviated by the inclusion in the 
medication dispensing unit 10 of a power cell 26 (such 
as a lithium cell) which is of sufficient lifetime to negate 
the need for recharging. Where the implantable portion 
10 is, in fact, not implanted but is employed externally 
other methods of recharging or even replacement of the 
power cell may be employed. The medication program- 
ming unit 24 provides output to a paper printer 32 
which provides hard, readable output that can be 
readily interpreted by a physician. 
Referring now to FIGS. 2 and 3, the medication 
dispensing unit 10 of an implantable programmable 
medication infusion system is shown. Medication is 
provided to the medication dispensing unit 10 by means 
of a hypodermic syringe 20 which penetrates the skin 34 
and passes through a conical aperture 35 and a self-seal- 
ing septum 36, preferably made of medical grade sili- 
cone rubber or the like, which covers an antechamber 
38 in leak-proof fashion. Medication is introduced into 
the antechamber 38 through syringe 20 at atmospheric 
pressure or under pressure the level of which is control- 
lable externally. A medication reservoir 22, in which 
the medication is stored under relatively constant pres- 
sure, is fed from the antechamber 38 via a ceramic filter 
42 and a one-way inlet pressure valve 44 which permits 
flow only from the antechamber 38 into the medication 
reservoir 22 when the pressure differential between 
them exceeds a predetermined threshold. 
The inlet ceramic filter 42 surrounds the antechamber 
38 and performs various functions which enhance the 
safety of the implantable portion 10 particularly in an 
implant environment. Besides filtering contaminants 
from medication being fed into the medication reservoir 
22, the ceramic filter 42 serves to limit the rate of medi- 
cation flow from the antechamber 38 into the reservoir 
22 or, conversely, from the reservoir 22 into antecham- 
ber 38 should the inlet pressure valve 44 leak. Should 
the septum 36 leak, the ceramic filter 42 together with 
the inlet pressure valve 44 prevents the inflow of body 
fluids into the medication reservoir 22. Further, should 
the inlet pressure valve 44 and the septum 36 both leak 
or otherwise deviate from optimal performance, the 
filter 42 would permit only a slow flow of body fluids to 
enter the medication reservoir 22, until body ambient 
pressure is achieved, at which time some medication 
could diffuse through the ceramic filter 42 but at a rate 
that would not be hazardous to a typical patient in 
which the system would be implanted. Furthermore, 
when this occurs an informational signal would be gen- 
erated. 
7 
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A liquid-vapor pressurant chamber 45 is separated 
from medication reservoir 22 by a flexible diaphragm 
46a. The liquid-vapor volume in the liquid-vapor cham- 
ber 45 preferably comprises a saturated vapor in equilib- 
rium with a small amount of Freon 113 liquid. Over 
normal body temperatures, Freon 113 has a linear pres- 
sure characteristic ranging from -4 psig (at 98”) to 
approximately -2.5 psig (at 104” F.). Using Freon 113, 
the medication reservoir 22 will be maintained at a 
pressure below that of the human body pressure up to 
altitudes of 8500 feet. For patients who may live above 
that altitude, other fluorocarbons at lower pressure may 
be employed. In this way, should both the septum 36 
and the inlet pressure valve 44 leak, the effect would be 
to cause body fluids to diffuse slowly through the inlet 
ceramic filter 42, into the medication reservoir 22 rather 
than to have a rapid flow of medication enter into the 
body where it could cause harm to the patient. Because 
of the pressure differential between the body and the 
medication reservoir 22, medication will not flow from 
the reservoir 22 into the body. As the amount of medi- 
cation in the medication reservoir 22 varies, the flexible 
diaphragm 46a moves up or down, with the Freon 113 
being converted either from liquid to vapor or vapor to 
liquid to provide an essentially constant pressure which 
will always be below one standard atmosphere and 
below normal body pressure. A medication reservoir 22 
having a volume of approximately 10 cc would be suffi- 
cient for most applications. This amount of concen- 
trated medication, insulin for example, could be fatal if 
injected over a short time. To prevent fatal leakage, the 
volume of the antechamber 38 is designed to have a safe 
dosage volume, e.g. less than 10% the size of the medi- 
cation reservoir 22. In the worst case, if the medication 
reservoir 22 had a leak into the antechamber 38 which 
also had a leak, only medication diluted with incoming 
body fluids due to the pressure differential would ini- 
tially enter the body. Such flow would be at a relatively 
slow diffusion rate because there would be zero pres- 
sure differential and because there is a very restrictive 
flow path. Under these conditions, the likelihood of 
leakage being fatal is minimized. As readily seen in FIG. 
2, varying the size or shape of the medication reservoir 
22 would be a simple modification because of the ar- 
rangement of elements in the system. A very important. 
characteristic of the reservoir is that it is all metal (in- 
cluding the diaphragm 46a of FIG. 2.) so that no mois- 
ture can diffuse out of the reservoir 22 that could dam- 
age any of the electronics in the implanted unit 10. 
Included in the liquid-vapor chamber 45 is a com- 
bined diaphragm position switch-moisture detector unit 
46 (shown enlarged in FIGS. 4 and 5) comprising a 
ceramic insulator substrate 47 to which is attached a 
movable electrical contact 48, and deposited metal sur- 
faces 50, 51, 52 and 53. When the medication reservoir 
is being filled, the flexible diaphragm 4 6 ~  will move 
outward, and when the medication reservoir 22 is full, 
the flexible diaphragm 46u will make physical contact 
with the movable electrical contact 48. Since the flexi- 
ble diaphragm 46a is preferably fabricated of metal and 
is therefore an electrical conductor, it will close an 
electrical circuit through the movable electrical contact 
48 and the deposited metal surface 50 which can be used 
to send out a signal by the telemetering transmitter 105 
of FIG. 8, to the medication programming system 12 of 
FIG. 7, to stop the infusion of medication. 
If body fluids leak into the medication reservoir 22, 
the flexible diaphragm 46a will move out further, result- 
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ing in the movable electrical contact 48 being forced to 
make electrical contact with the metal surface 51 of 
FIG. 4. This switch closure would cause the program- 
mable information signal generator 70 of FIG. 8 to 
provide an appropriate informational signal which 
would be sent to warn the patient. By way of example, 
the signal to the patient might be in the form of an 
electrical “tickle” stimulation applied subcutaneously 
by means of a stimulation electrode 51a of FIG. 8 dis- 
posed on the upper surface of the unit lO(see FIG. 2). 
Another useful means for warning the patient would be 
by means of an acoustical transducer typically within 
the implanted device that would provide the patient 
with an audible alarm. 
In the presence of Freon 113, but in the absence of 
moisture, the electrical resistance between the depos- 
ited metal surfaces 52 and 53 which collectively form 
the moisture detector 54 (see FIG. 8) is greater than 1 
megohm. If however, moisture is released into the liq- 
uid-vapor chamber 45, either through a leaky flexible 
diaphragm 460 or if body fluids leak through the sealed 
outer cover 60 into the liquid-vapor chamber 45, then 
the moisture detector 54 will experience a detectable 
decrease in electrical resistance across the metal sur- 
faces 52 and 53. If this occurs, moisture detector 54 
initiates an informational‘signal to be sent to the patient 
to indicate a leak in the implanted unit 10. 
The medication reservoir 22 and liquid-vapor cham- 
ber 45 are separated from the other portions of the 
medication dispensing unit 10 by wall 55 (forming the 
top of reservoir 22, as viewed in FIG. 2) and fluidically 
isolated from the other elements of the system by means 
of the inlet pressure valve 44 and a pump inlet valve 73 
(see FIG. 7) which connects the reservoir 22 to a pulsa- 
tile pump 57 (shown in detail in FIG. 7). The remaining 
elements of the implantable medication dispensing unit 
10 are shown in FIG. 2 above and isolated from the 
reservoir 22 (by wall 55) and include an electronics 
compartment or section 56 containing a power cell 
subsection 58. As is readily seen in FIG. 2, an outer 
cover 60 isolates the medication reservoir chamber 22 
and liquid-vapor pressurant chamber 45 as well as the 
pump 57 and the electronics compartment or section 56 
(and the power cell subsection 58) from the external 
environment. A moisture detector 59, of the same de- 
sign as detector 54 described above, would be located in 
an electronics section 56 (of FIG. 2) so that it could 
detect and provide an informational signal to the patient 
if either a medication leak occurs through the wall 55 or 
body fluids penetrate the top portion of the sealed outer 
cover 60. 
An informational signal generator 70, such as that 
shown in FIG. 6, can be used in signalling or alerting a 
patient of a predetermined condition or in checking the 
medication dispensing unit 10 (of FIG. 2). The genera- 
tor 70 has a plurality of inputs A1 through AN. The A1 
through ANinputs are provided by a command decoder 
(104 of FIG. 8), the inputs A1 through AN selectively 
switching elements SI through SN in amplitude select 
element 72 to provide 2Npossible, programmable volt- 
age levels. The programmable voltage level is applied 
to an amplifier transistor circuit 74, which is biased by a 
voltage VA. The output signal Vo of the circuit 74 can 
be applied to a lead 75 in contact with the patient if an 
input WIN) to a FET 76 is provided. A capacitor 77, 
preferably of one microfarad, is located between the 
alarm output signal Vo and the patient to generate a 
patient-sensed voltage across load Rp ranging between 
9 
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one and ten volts selectable in programmable steps. The 
load Rp can provide electrical stimulation (e.g. by means 
of the stimulation electrode 51a in FIG. 2), heat, or 
audio alarm output to inform the patient. In the case of 
an informational (alarm) signal provided by electrical 
stimulation, the load Rp is the electrical load caused by 
the patient’s tissue and fluid surrounding the alarm elec- 
trode 51a. When the FET 76 conducts, the load Rp is 
short-circuited. When the FET 76 is not conducting 
(there is no VIN), a stimulating signal through the load 
Rp can be effected. The information signal generator 70 
input V ~ ~ m a y  be high (or “on”) when any one of a 
plurality of selected conditions is detected and sig- 
nalled, such as: the fill limit of reservoir 22 has been 
reached (when diaphragm 46a connects to switch 
contact 48 in FIG. 5), body fluids have entered reser- 
voir 22 (when contact 48 connects to surface 51), un- 
wanted moisture has been detected within the unit 10 
(by detector 54 or 59 in FIG. 8), and the like. 
The pump 57 shown in FIG. 7 is discussed in detail in 
the above-referenced patent application. In an output 
chamber of the pump 57 is a transducer 78 which senses 
when a pulsatile dose of medication is dispensed. Trans- 
ducer 78 detects pressure build-up in the output cham- 
ber of pump 57. It may be noted that other types of 
transducers are available which can detect a pulsatile 
flow through an output tube. Each pulse of medication 
is communicated by the transducer 78 as an electrical 
pulse and therefore, based upon prior knowledge of the 
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volume of medication in reservoir 22 when fulrand the 30 
volume of medication dispensed for each actuation of 
pump 57, it is obvious that at any given time the current 
volume of medication remaining in the reservoir 22 can 
be determined by merely recording a count of the num- 
ber of pulses produced by transducer 78. To promote a 35 
pulse of medication, a coil 79 (or other similar means of 
ieciprocating a variable volume pump storage chamber 
80) is provided with a pulse of electrical energy. 
By comparing the number of electrical pulses to the 
coil 79 with the number of electrical pulses produced by 
the transducer 78, an operational check is performed 
and indicates, for example, that the output of the medi- 
cation dispensing system is clogged. Thus, as seen in 
FIG. 8, electrical pulses from the transducer 78 and a 
count of electrical pulses to the coil 79 are communi- 
cated to and stored in a pulse recorder 82. 
The output of the transducer 78 is also applied to a 
pulse rate detector 84. The pulse rate detector 84 pro- 
vides a hard-wired “insufficient rate” command input 
which provides a programmable lower medication dis- 
pensing limit. That is, when less than a physician pre- 
scribed minimum of medication is delivered to the 
body, the rate detector 84 signals information signal 
generator 70 that an informational (alert) signal to the 
patient is to be generated. To effect this signal, an input 
(line 844 to the programmable information signal gen- 
erator 70 (of FIGS. 6 and 8) is connected through 
switch inputs, such as V I N ~ ~  FIG. 6. Although shown 
as a FET switch input, VIN may provide input to an- 
other form of switch connected to a programmable 
information signal generator 70 which may have a pulse 
coded memory and varied outputs corresponding to 
inputs for different conditions (as shown in FIG. 8.) 
Overpressure (from an over-filled reservoir), fluid de- 
tection, pulse count discrepancy, excessive pulse re- 
quest, low battery voltage, and the like can thus stimu- 
late an alarm signal by entering a line like V r ~ o f  FIG. 
6. 
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For example, the pulse rate detector 84 sends trans- 
ducer pulse rate information to the pulse recorder 82, 
which information is compared by comparator circuitry 
in the pulse recorder 82 to the electrical pulses over the 
same period from the coil 79. A discrepancy between 
the two counts results in a signal to the information 
signal generator 70 over line 8242, as seen in FIG. 8 
which causes the FET 76 (FIG. 6) to assume a high 
impedance state and a current to pass through stimula- 
tion electrode Ha. As noted earlier, thermal, acoustic, 
or other similar stimulation to the body might be used in 
place of or in combination with the electrical stimula- 
tion. 
As seen in FIG. 8, the electronics portion of medica- 
tion dispensing unit 10 (enclosed by dashed line 56 of 
FIG. 8) communicates with a communication head 16 
which is external to the body (for both implanted and 
external embodiments). Communication may be by wire 
for external embodiments or, for implantable or external 
embodiments, by radiant energy (in electromagnetic, 
alternating magnetic, or other remote signal forms). 
The communication head 16, in the FIG. 8 embodi- 
ment, provides both power and command inputs, as 
well as receiving telemetry output. More specifically, 
input power is provided by means of an alternating 
field, e.g. a magnetic field, which is communicated to a 
pickup coil 92 which is connected to other elements of 
the electronics section 56. The pickup coil 92 receives a 
power signal and passes it on to a full wave rectifier 94. 
One rectified output from the full-wave rectifier 94 
enters a battery charge control 96 which provides a 
fixed DC charging signal to a power cell 26. The power 
cell 26 can be a nickel-cadmium cell which is readily 
rechargeable off a rectified signal at a typical frequency 
of 20 kHz. Alternatively, a lithium-type solid state bat- 
tery can be used instead of the nickel-cadmium cell in 
which case the charging circuitry could be eliminated, 
the lithium-type battery providing sufficient power 
over a long term, thereby obviating the need for re- 
charging. The power cell 26 provides a biasing voltage 
to a switch 98, the output of which enters the pulsing 
coil 79 previously described. 
In addition to providing power to the power cell 26, 
rectified power is also introduced to a DC-to-DC con- 
verter 100 the purpose of which is to provide power at 
the proper levels to the various loads in the system. In 
addition to the AC power signal, pickup coil 92 may 
also receive a train of serial digital bits, e.g. from the 
communication head 16. The digital bits comprise com- 
mands for programmable inputs which are conveyed, 
via the pickup coil 92 to a command receiver 102. The 
signals from the command receiver 102 enter a com- 
mand decoder 104 which determines if the digital bits 
are in a proper format and, if so, what action in the 
system the commands dictate. To allow remote verifica- 
tion of the information decoded in command decoder 
104, the decoded signals are transmitted back to the 
communication head 16 by means of a telemetry trans- 
mitter 105 and a telemetry coil 107. It should also be 
noted that the full wave rectifier 94, the battery charge 
control 96, the command receiver 102, the command 
decoder 104 and telemetry transmitter 105 could be 
powered only when an AC signal is picked up by the 
pickup coil 92. As seen in FIG. 8, for example, the 
command receiver 102 receives operating power from 
the full-wave rectifier 94 enabling it to convey signals 
from the coil 92 to the command decoder 104. It should 
be obvious that a power savings is achieved by only 
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powering the command receiver etc. when necessary 
and, moreover, prevents the possibility of detecting 
stray signals as commands. To be sure, the power sav- 
ings achieved could make possible the use of the afore- 
mentioned lithium cell which would not require re- 
charging. 
From the command decoder 104, programmable in- 
puts and other commands can be provided to a number 
of elements. A programmable base rate is entered into a 
base rate memory unit 106 which stores a value indicat- 
ing the number of pulses of medication which are to be 
provided to a patient during a normal preselected per- 
iod of time. A second programmable input is provided 
to a patient-controlled rate memory unit 108 which 
stores a value indicating a number of pulses of medica- 
tion that are requested by the patient (with a patient 
programming unit 14) to be introduced into the body. 
Associated with the base rate memory unit 106 is a 
hardwired base rate limit control 110 which sets a maxi- 
mum rate that can override requests of the base rate 
memory unit 108 which are excessive. Similarly, a hard- 
wired patient-controlled rate limit control 112 provides 
a fixed maximum number of pulses which can be pro- 
vided at a time after a meal or at other times and under 
other conditions such as exercise. As long as the base 
rate and patient-controlled rate values stored in mem- 
ory units 106 and 108 respectively, do not exceed the 
hardwired values fixed within limit controls 110 and 
112, respectively, an output pulse is provided to the 
switch 98 to stimulate a pulse output from pulsing coil 
79. Should the rate of either memory unit 106 or 108 
exceed the hardwired limits in the limit control ele- 
ments 110 or 112, respectively, a “rate request exceeds 
limit” signal is fed from the limit control element 110 or 
112 into the programmable information signal generator 
70 which provides an electrical signal to the load Rp. 
The patient (in one form of the invention) is informed 
by means of a stimulation that more medication than 
permitted has been requested. 
12 
and 108, in order to exceed the hardwired base rate and 
the hardwired patient-controlled rate, respectively. 
When the rates are exceeded, the information signal 
generator 70 will provide a signal. In this way, the 
5 information signal generator 70 can be used to check the 
operation of the limit control elements 110 and 112, 
inform the physician of operational problems via means 
V,, and also familiarize the patient with the correspond- 
ing stimulation emitted by the load Rp. 
The programmable information signal generator 70 
also receives inputs from the movable electrical contact 
48 and the moisture detectors 54 and 59 (see FIGS. 2 
and 4). If body fluids leak into the medication reservoir 
22, the movable electrical contact 48 will make electri- 
15 cal contact with 51, indicating this fault condition to the 
patient by activating the information signal generator 
70. If the patient was unconscious, voltage levels on the 
patient’s skin at the site of the medication dispensing 
unit 10 could be used by the physician to detect if a 
20 deviation has occurred and could, with a pulse-coded 
embodiment, indicate which selected deviation in nomi- 
nal performance it was. Further, as previously de- 
scribed, should fluid leak out of the medication reser- 
voir 22 or if body fluid should leak in through the enclo- 
25 sure 60, the moisture detector 54 would sense such 
leakage and, as shown in FIG. 8, would provide input to 
the information signal generator 70. Similarly, moisture 
detector 59 would signal the presence of medication or 
body fluid in the electronics compartment 56. Still an- 
30 other input to the information signal generator 70 
comes from the power cell 26 associated with the tran- 
sistor switch 98. The voltage level of the power cell 26 
is thus communicated to the signal generator 7 0  a stim- 
ulation signal being generated when the battery voltage 
It should be noted that the various mentioned condi- 
tions in the system result in stimulations each of which 
may all be the same or which may be different in stimu- 
lation pulse amplitude, duration, periodicity, interpulse 
10 
35 is below a predetermined level. 
It should be noted that the signal to the load Rp, e.g. 40 spacing or other coding. For example, the stimulation 
an electrode, can serve the dual function of not only may range between one to ten volts; may vary in fre- 
providing the patient with a subcutaneous, heat, or quency over a wide range; and, most importantly, a 
audible stimulation but may also be detected by the variety of unique pulse patterns may be used to indicate 
communication head 16, via signal transfer means V,,, the various selected conditions or deviations in nominal 
and may be communicated to the physician, thereby 45 performance. 
indicating that a deviation from optimal system status As discussed previously, additional signals to initiate 
has occurred. As shown in FIG. 8, the load Rp will be an informational signal to the patient are derived from 
isolated and electrically insulated from the outside of pulse count information in the pulse recorder 82 and 
the enclosure 60 of the medication dispensing unit 10. pulse rate detector 84 of FIG. 8 and might also be de- 
A particularly significant feature of the invention 50 rived from any of a variety of optical, capacitive, induc- 
resides in the programmability of the information signal tive, liquid crystal, or other reservoir level measuring 
generator 70 based on input commands from the com- elements which might be utilized to inform the patient 
mand decoder 104. The voltage produced by the signal (or physician) when say only 10% or a 5 days supply of 
generator 70 across the load Rp can be varied in re- the medication remains in the reservoir. 
sponse to signals emanating from the communication 55 Referring to FIG. 9, three pulse-coded deviation 
head 16 and channelled through the command receiver signals are illustrated. In FIG. 9(A), two L.5 second 
102 to the command decoder 104 and into inputs A1 signals five seconds apart are repeated at fifteen minute 
through A, of amplitude select element 72 (showfi in intervals to indicate insufficient medication rate. In 
FIG. 6). FIG. 9(B), two 1.5 second signals ten seconds apart are 
In addition, in order to check the proper operation of 60 repeated at thirty minute intervals to indicate a moisture 
the system, the command decoder 104 can receive test leak. In FIG. 9(C), two 1.5 second signals fifteen sec- 
signals which can stimulate actual occurrences to deter- onds apart are repeated every forty-five minutes to 
mine whether the circuitry in the electronic section 56 indicate that the medication reservoir contains body 
is operating properly. For example, extra pulses from fluids. Similar coding or a variation thereof can also be 
the command decoder 104 can be entered into the hard- 65 employed to indicate low battery voltage and undesir- 
wired limit control elements 110 and 112. These extra ably high medication rate requests. 
pulses can be added to the pulses provided by the base It may also be desirable to have the same pattern for 
rate and the patient-controlled rate memory units 106 all alarms, but have a unique informational signal be 
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provided only for the physician to determine the spe- 
cific cause of that alarm. If that was done, then any one 
of the signal formats of FIG. 9 could be used as the 
alarm pattern for the patient. 
Various other modifications, adaptations and alter- 5 
ations are of course possible in light of the above teach- 
ings. Therefore, it should be understood at this time that 
within the scope of the appended claims the invention 
scribed. 
a means, responsive to said detecting means, for acti- 
vating said acoustical transducer to generate an 
acoustical signal when said at least one predeter- 
mined condition is detected. 
5. The apparatus of claim 1 or 2, wherein said alerting 
a tickle for applying a subcutaneous electrical 
means comprises: 
tickle to an intracorporeal location; and, 
vating said tickle means to generate an electrical 
tickle when said at least one predetermined condi- 
tion is detected. 
6. An infusion system for providing medication to a 
an infusion apparatus for implantation in said living 
body, including, 
a medication reservoir for storing selected medica- 
tion; 
a means for detecting the presence of at least one 
predetermined condition regarding the opera- 
tional state of the infusion apparatus; 
a tickle means for applying a subcutaneous electrical 
tickle to an intracorporeal location; and, 
a patient alerting means, responsive to said detecting 
means, for activating said tickle means to generate 
an electrical tickle when said at least one predeter- 
mined conditions is detected, wherein said infusion 
system contains an extracorporeal transmitter for 
sending a command signal to set the intensity of 
said electrical tickle and wherein said infusion ap- 
paratus further includes a receiver means operably 
coupled to said patient alerting means for detecting 
said command signal and wherein said patient alert- 
ing means includes a means for setting the intensity 
of said electrical tickle in response to said received 
7. An infusion system for providing medication to a 
an infusion apparatus for implantation in said living 
body, including, 
a medication reservoir for storing selected medica- 
tion; 
a means for detecting the presence of at least one 
predetermined condition regarding the opera- 
tional state of the infusion apparatus; 
may be practiced Otherwise than as de- a means, responsive to said detecting means, for 
lo 
What is claimed is: 
1. An infusion system for providing medication to a 
an infusion apparatus for implantation in said living 
body, including, 
a medication reservo-ir for storing selected medica-. 
tion; 
a pump means for infusing a fixed dosage of said 
medication into said living body with each pump 
actuation; 
an infusion output from which doses of medication 
exit the infusion apparatus and are dispensed to 
the patient; 
a control means for applying an electrical pulse to 
the pump means to delivery said fixed dosage of 25 
medication; 
a means for detecting the presence of at least one 
predetermined condition regarding the opera- 
tional state of the infusion apparatus, wherein 
said detecting means comprises a condition sen- 30 
sor, disposed at the infusion output, for sensing 
the dispensing of a dose of medication, and, a 
comparing means for detecting when the number 
of medication dosages detected by said condition 
sensor deviates from the number of applied elec- 35 
trical pulses generated by said control means; 
and, command signal. 
a means, operably coupled to said detecting means, 
for alerting said patient when said at least one 
predetermined condition is detected. 
2. An infusion system for providing medication to a 
an infusion apparatus for implantation in said living 
living body of a patient comprising: 
living body of a patient comprising: 
2o 
living body of a patient comprising: 
40 
living body of a patient comprising: 
body, including, 
a medication reservoir for storing selected medica- 45 
tion; 
a means for maintaining the pressure in the medica- 
tion reservoir below a predetermined level that 
is less than ambient body pressure; 
a means for detecting the presence of at least one 50 
predetermined condition regarding the opera- 
tional state of the infusion apparatus, wherein 
said detecting means comprises a condition sen- 
sor for detecting when the fluid level in the res- 
ervoir exceeds a predetermined fill level higher 55 
than a normal full level, indicating that body 
fluids have leaked into the infusion apparatus; 
and, 
a means, operably coupled to said detecting means, 
for alerting said patient when said at least one 60 
predetermined condition is detected. 
an acoustical transducer; 
a patient alerting means, responsive to said detect- 
ing means, for activating said acoustical trans- 
ducer to generate an acoustical signal when said 
at least one predetermined condition is detected, 
wherein said infusion system contains an extra- 
corporeal transmitter for sending a command 
signal to set the intensity of said acoustical signal 
and wherein said infusion apparatus further in- 
cludes a receiver means operably coupled to said 
patient alerting means for detecting said com- 
mand signal and wherein said patient alerting 
means includes a means for setting the intensity 
of said acoustical signal in response to said re- 
ceived command signal. 
8. An infusion apparatus for implantation into a living 
3. The apparatus as in claim 2, wherein said detecting 
means further includes a second condition Sensor for 
detecting when the pressure in the medication reservoir 
exceeds a predetermined pressure level. 65 a housing; 
4. The apparatus of claim 1 or 2, wherein said alerting 
means comprises: 
an acoustic transducer; and, ing; 
body of a patient comprising: 
a medication reservoir for storing selected medica- 
tion, said medication reservoir located in said hous- 
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a pump means for infusing a fixed dosage of said 
medication into said living body with each pump 
actuation; 
an infusion output coupled to said pump means from 
which dosages of medication exit the infusion appa- 
ratus and are dispensed into the patient; 
a control means for applying electrical pulses to said 
pump means, each electrical pulse actuating said 
pump means to deliver said fixed dosage of medica- 
tion; 
a power supply; 
a means associated with said medication reservoir for 
maintaining the pressure in said medication reser- 
voir below a predetermined level that is less than 
ambient pressure; 
a means for monitoring at least two preddermined 
conditions regarding the operational state of the 
infusion apparatus, said at least two conditions 
selected from the following group of conditions: 
a. medication level in said medication reservoir is at 
a preselected low level, 
b. presence of medication or body fluids between 
the medication reservoir and the housing, 
c. a difference between the number of electrical 
pulses provided by said control means to said 
pump means and the number of fixed dosages of 
medication delivered by said pump means 
through said infusion output; 
d. medication level in said medication reservoir 
exceeds a predetermined fill level higher than a 
normal full level, indicating that body fluids 
have leaked into the infusion apparatus, 
e. pressure in the medication reservoir exceeds a 
predetermined negative pressure level, and 
f. power supply output falls below a preset level, 
an acoustical transducer; and, 
a patient alerting means, responsive to said monitor- 
ing means for activating said acoustical transducer 
to generate an acoustical signal when at least one of 
said predetermined condition is detected. 
9. An infustion apparatus for implantation into a liv- 
a housing; 
ing body of a patient comprising: 
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a medication reservoir for storing selected medica- 
tion, said medication reservoir located in said hous- 
ing; 
a pump means for infusing a fixed dosage of said 
medication into said living body with each pump 
actuation; 
an infusion output coupled to said pump means from 
which dosages of medication exit the infusion appa- 
ratus and are dispensed into the patient; 
a control means for applying electrical pulses to said 
pump means, each electrical pulse actuating said 
pump means to deliver said fixed dosage of medica- 
tion; 
a power supply; 
a means associated with said medication reservoir for 
maintaining .the pressure in said medication reser- 
voir below a predetermined level that is less than 
ambient pressure; 
a means for monitoring at least two medetermined 
a 
a 
conditions regarding the operationil state of the 
infusion apparatus, said at least two conditions 
selected from the following group of conditions: 
a. medication level in said medication reservoir is at 
a preselected low level, 
b. presence of medication or body fluids between 
the medication reservoir and the housing, 
c. a difference between the number of electrical 
pulses provided by said control means to said 
pump means and the number of fixed dosages of 
medication delivered by said pump means 
through said infusion output; 
d. medication level in said medication reservoir 
exceeds a predetermined fill level higher than a 
normal full level, indicating that body fluids 
have leaked into the infusion apparatus, 
e. pressure in the medication reservoir exceeds a 
predetermined negative pressure level, and 
f. power supply output falls below a preset level, 
tickle means for applying a subcutaneous electrical 
tickle to an intracorporeal location; and, 
patient alerting means, responsive to said monitor- 
ing means, for activating said tickle means to gen- 
erate an electrical tickle when at least 0-ne of said 
predetermined conditions is detected. * * * * *  
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